Cargando…
Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
INTRODUCTION: The incidence of hepatocellular carcinoma (HCC) ranks sixth in the world, but its mortality is the third highest due to the lack of early diagnostic markers. Nowadays, the increase of autoantibody levels has been found in many cancers, and many studies have begun to pay attention to th...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447394/ https://www.ncbi.nlm.nih.gov/pubmed/32846849 http://dx.doi.org/10.1097/MD.0000000000021887 |